Property | Value |
?:abstract
|
-
PURPOSE: The role of tracheostomy in COVID-19-related ARDS is unknown. Nowadays, there is no clear indication regarding the timing of tracheostomy in these patients. METHODS: We describe our synergic experience between ENT and ICU Departments at University Hospital of Modena underlining some controversial aspects that would be worth discussing tracheostomies in these patients. During the last 2 weeks, we performed 28 tracheostomies on patients with ARDS due to COVID-19 infection who were treated with IMV. RESULTS: No differences between percutaneous and surgical tracheostomy in terms of timing and no case of team virus infection. CONCLUSION: In our experience, tracheostomy should be performed only in selected patients within 7- and 14-day orotracheal intubation.
|
?:creator
|
|
?:doi
|
-
10.1007/s00405-020-05982-0
|
?:doi
|
|
?:journal
|
-
Eur_Arch_Otorhinolaryngol
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/05c045fe5d904657c9814d2264778c6a9c5ad8bf.json
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7174541.xml.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Tracheostomy in the COVID-19 pandemic
|
?:type
|
|
?:year
|
|